These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

16 related articles for article (PubMed ID: 2997350)

  • 1. Drug development for hepatocellular carcinoma: knowing the past helps to understand the future.
    Chan SL
    Oncologist; 2014 Nov; 19(11):1115-7. PubMed ID: 25223461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined cis-platinum and alpha interferon therapy of advanced hepatocellular carcinoma.
    Ji SK; Park NH; Choi HM; Kim YW; Lee SH; Lee KH; Ahn SY; Lee SU; Han BH; Park BC
    Korean J Intern Med; 1996 Jan; 11(1):58-68. PubMed ID: 8882477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of co-administration of uracil and tegafur (UFT) in hepatocellular carcinoma. Tokyo Liver Cancer Chemotherapy Study Group.
    Jpn J Clin Oncol; 1985 Sep; 15(3):559-62. PubMed ID: 2997511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Futraful therapy on liver cancer.
    Kurihara M; Shirakabe H; Izumi T; Miyasaka K; Ariyama J
    Clin Oncol; 1977 Mar; 3(1):33-49. PubMed ID: 193664
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: implication for antiangiogenic approach to hepatocellular carcinoma.
    Yau T; Chan P; Pang R; Ng K; Fan ST; Poon RT
    Cancer; 2010 Nov; 116(21):5022-9. PubMed ID: 20629034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of advanced hepatocellular carcinoma responding to suppository of Tegafur].
    Kudo K; Arakawa A; Takagi Y; Nishimura R; Yamashita Y; Takahashi M
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):747-50. PubMed ID: 9571975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
    Tsurumachi T; Yamamoto H; Watanabe K; Honda I; Watanabe S; Yamada S; Jingu K; Satomi D; Fujita M
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):631-4. PubMed ID: 8678524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled study of intravenous doxorubicin versus oral tegafur in patients with hepatocellular carcinoma.
    Okazaki N; Yoshino M; Yoshida T; Hijikata A
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):556-61. PubMed ID: 2997350
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.